Beam Therapeutics
(NASDAQ:BEAM)
$33.61
-0.35[-1.03%]
Last update: 1:56PM Get Real Time Here
75%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
60
0100

Beam Therapeutics Stock (NASDAQ:BEAM), Quotes and News Summary

Beam Therapeutics Stock (NASDAQ: BEAM) stock price, news, charts, stock research, profile.

Open$34.080
Close-
Volume / Avg.550.289K / 1.375M
Day Range33.478 - 34.170
52 Wk Range16.950 - 49.500
Market Cap$2.745B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
20.85%
Days to Cover9.09
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Oct 23
1
Dec 23
1
Jan
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Beam Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BEAM
IDYA

FAQ

Q

How do I buy Beam Therapeutics (BEAM) stock?

A

You can purchase shares of Beam Therapeutics (NASDAQ: BEAM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Beam Therapeutics's (BEAM) competitors?

Q

What is the target price for Beam Therapeutics (BEAM) stock?

A

The latest price target for Beam Therapeutics (NASDAQ: BEAM) was reported by BMO Capital on Wednesday, March 27, 2024. The analyst firm set a price target for 57.00 expecting BEAM to rise to within 12 months (a possible 69.59% upside). 15 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Beam Therapeutics (BEAM)?

A

The stock price for Beam Therapeutics (NASDAQ: BEAM) is $33.61 last updated Today at March 28, 2024 at 1:56 PM EDT.

Q

Does Beam Therapeutics (BEAM) pay a dividend?

A

A quarterly cash dividend of $0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.

Q

When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?

A

Beam Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Q

Is Beam Therapeutics (BEAM) going to split?

A

There is no upcoming split for Beam Therapeutics.

Q

What sector and industry does Beam Therapeutics (BEAM) operate in?

A

Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch